Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

BACKGROUND: The activation of dendritic cells (DCs) is pivotal for generating antigen-specific T-cell responses to eradicate tumor cells. Hence, immunotherapies targeting this interplay are especially intriguing. Moreover, it is of interest to modulate the tumor microenvironment (TME), as this harsh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenthe, Jessica, Eriksson, Emma, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Loskog, Angelica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373363/
https://www.ncbi.nlm.nih.gov/pubmed/37501121
http://dx.doi.org/10.1186/s12967-023-04374-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373363/
https://www.ncbi.nlm.nih.gov/pubmed/37501121
http://dx.doi.org/10.1186/s12967-023-04374-2

Ejemplares similares